Online citations, reference lists, and bibliographies.
← Back to Search

Nanomedical Innovation: The SEON-concept For An Improved Cancer Therapy With Magnetic Nanoparticles.

S. Lyer, R. Tietze, H. Unterweger, J. Zaloga, R. Singh, Jasmin Matuszak, Marina Poettler, R. Friedrich, Stephan Duerr, I. Cicha, C. Janko, C. Alexiou
Published 2015 · Medicine, Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
Nanomedicine offers tremendous opportunities for the development of novel therapeutic and diagnostic tools. During the last decades, extensive knowledge was gained about stabilizing and the coating of nanoparticles, their functionalization for drug binding and drug release and possible strategies for therapies and diagnostics of different diseases. Most recently, more and more emphasis has been placed on nanotoxicology and nanosafety aspects. The section of experimental oncology and nanomedicine developed a concept for translating this knowledge into clinical application of magnetic drug targeting for the treatment of cancer and other diseases using superparamagnetic iron oxide nanoparticles. This approach includes reproducible synthesis, detailed characterization, nanotoxicological testing, evaluation in ex vivo models, preclinical animal studies and production of superparamagnetic iron oxide nanoparticles according to good manufacturing practice regulations.
This paper references
10.1016/J.JMMM.2011.06.055
Quantitative targeting maps based on experimental investigations for a branched tube model in magnetic drug targeting
K. Gitter (2011)
10.1039/B409601K
Synthesis of monodisperse iron oxide nanocrystals by thermal decomposition of iron carboxylate salts.
W. W. Yu (2004)
10.1016/j.addr.2013.07.011
Nanotechnology as a therapeutic tool to combat microbial resistance.
Robert Y. Pelgrift (2013)
10.1186/1477-3155-10-15
The cytotoxicity of polycationic iron oxide nanoparticles: Common endpoint assays and alternative approaches for improved understanding of cellular response mechanism
C. Hoskins (2012)
Visualisation of tumour regression after local chemotherapy with magnetic nanoparticles - a pilot study.
S. Lyer (2010)
10.1155/2010/597304
Mitoxantrone Loaded Superparamagnetic Nanoparticles for Drug Targeting: A Versatile and Sensitive Method for Quantification of Drug Enrichment in Rabbit Tissues Using HPLC-UV
R. Tietze (2010)
10.1177/028418519303400103
Mr Lymphography Using Iron Oxide Particles
M. Taupitz (1993)
10.3390/ijms14047341
Magnetic Drug Targeting Reduces the Chemotherapeutic Burden on Circulating Leukocytes
C. Janko (2013)
10.2147/IJN.S63433
Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery
H. Unterweger (2014)
10.1088/0953-8984/18/38/S24
Drug loaded magnetic nanoparticles for cancer therapy
R. Jurgons (2006)
10.1016/J.BIOMATERIALS.2004.10.012
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
A. Gupta (2005)
10.1016/J.JMMM.2006.11.158
Sterically stabilized water based magnetic fluids : Synthesis, structure and properties
D. Bica (2007)
10.1007/s00418-011-0780-8
Visualization of superparamagnetic nanoparticles in vascular tissue using XμCT and histology
R. Tietze (2011)
10.1088/0031-9155/55/3/005
Magnetorelaxometry for localization and quantification of magnetic nanoparticles for thermal ablation studies.
H. Richter (2010)
10.1016/j.devcel.2010.09.007
Integrin-Linked Kinase Controls Microtubule Dynamics Required for Plasma Membrane Targeting of Caveolae
S. Wickström (2010)
10.1016/J.TIV.2006.10.007
In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells.
M. Davoren (2007)
10.1021/nn506789y
Sol-gel synthesis and electrospraying of biodegradable (P2O5)55-(CaO)30-(Na2O)15 glass nanospheres as a transient contrast agent for ultrasound stem cell imaging.
F. Foroutan (2015)
10.1073/pnas.242435499
Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat
M. Hoehn (2002)
10.1039/c1nr10173k
Stabilization and functionalization of iron oxide nanoparticles for biomedical applications.
E. Amstad (2011)
10.1128/AAC.01584-09
In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
D. Andes (2010)
10.3390/ijms16059368
Different Storage Conditions Influence Biocompatibility and Physicochemical Properties of Iron Oxide Nanoparticles
Jan Zaloga (2015)
10.1088/0953-8984/20/20/204152
Microcomputed tomography analysis of ferrofluids used for cancer treatment.
H. Rahn (2008)
10.1016/J.JCONREL.2007.06.009
Gold nanoparticles enable selective light-induced contents release from liposomes.
Lauri Paasonen (2007)
10.1515/ntrev-2013-0011
Magnetic nanoparticles for cancer therapy
Stephan Duerr (2013)
10.1016/j.ejca.2012.12.027
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.
J. Ferlay (2013)
10.1016/j.nano.2013.05.001
Efficient drug-delivery using magnetic nanoparticles--biodistribution and therapeutic effects in tumour bearing rabbits.
R. Tietze (2013)
10.1021/cr068445e
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
S. Laurent (2008)
10.1021/mp3001155
Analysis of trajectories for targeting of magnetic nanoparticles in blood vessels.
A. Heidsieck (2012)
10.1016/J.COLSURFA.2013.01.023
Adsorption of organic acids on magnetite nanoparticles, pH-dependent colloidal stability and salt tolerance
E. Tombácz (2013)
10.1021/cr300068p
Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications.
L. H. Reddy (2012)
10.4333/KPS.2010.40.S.063
Solid Lipid Nanoparticles as Drug Delivery System for Water-Insoluble Drugs
Rihua Li (2010)
Real-time cell analysis of human cancer cell lines after chemotherapy with functionalized magnetic nanoparticles.
Stephan Duerr (2012)
10.1021/jz2014727
Small-Angle X-ray Scattering Investigations of Biomolecular Confinement, Loading, and Release from Liquid-Crystalline Nanochannel Assemblies.
A. Angelova (2012)
10.1118/1.3271344
Particle size, magnetic field, and blood velocity effects on particle retention in magnetic drug targeting.
E. Cherry (2010)
10.1016/J.IJMULTIPHASEFLOW.2013.11.007
A comprehensive model of magnetic particle motion during magnetic drug targeting
E. Cherry (2014)
Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting.
C. Alexiou (2007)
10.1016/j.ultrasmedbio.2011.05.850
Treatment of rabbit liver cancer in vivo using miniaturized image-ablate ultrasound arrays.
T. Mast (2011)
10.1088/0953-8984/26/17/176004
The influence of hydrodynamic diameter and core composition on the magnetoviscous effect of biocompatible ferrofluids.
J. Nowak (2014)
10.1084/JEM.126.5.881
IN VITRO CULTIVATION AND IMMUNOFLUORESCENT STUDIES OF TRANSPLANTABLE CARCINOMAS Vx2 AND Vx7
T. Osato (1967)
Locoregional cancer treatment with magnetic drug targeting.
C. Alexiou (2000)
10.1016/j.tips.2013.05.006
Understanding platinum-induced ototoxicity.
T. Langer (2013)
10.1021/bc100354m
Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages.
M. Kamat (2010)
10.1517/17425247.2014.924501
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges
S. Laurent (2014)
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.
A. Lübbe (1996)
10.2147/IJN.S82714
Flow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methods
R. Friedrich (2015)
10.1107/S002188980301104X
Identification of aggregates of magnetic nano­particles in ferrofluids at low concentrations
D. Eberbeck (2003)
10.1109/TASC.2005.864457
A High Field Gradient Magnet for Magnetic Drug Targeting
C. Alexiou (2006)
10.1016/j.atherosclerosis.2009.04.034
Shear stress preconditioning modulates endothelial susceptibility to circulating TNF-alpha and monocytic cell recruitment in a simplified model of arterial bifurcations.
I. Cicha (2009)
10.1016/S0304-8853(00)01256-7
Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting
C. Alexiou (2001)
10.1517/17425240802662795
Magnetic targeting for site-specific drug delivery: applications and clinical potential
B. Polyak (2009)
10.2147/IJN.S68539
Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility
J. Zaloga (2014)
10.2174/092986710791959765
Nanomedicine: magnetic nanoparticles and their biomedical applications.
R. Banerjee (2010)
10.1002/cmmi.391
Cytotoxicity of iron oxide nanoparticles made from the thermal decomposition of organometallics and aqueous phase transfer with Pluronic F127.
Marcela Gonzales (2010)
10.1038/nbt875
The potential environmental impact of engineered nanomaterials
V. Colvin (2003)
10.1007/s00270-009-9583-x
Thermoablation of Malignant Kidney Tumors Using Magnetic Nanoparticles: An In Vivo Feasibility Study in a Rabbit Model
P. Bruners (2009)
10.1166/JNN.2006.464
Medical applications of magnetic nanoparticles.
C. Alexiou (2006)
10.1146/annurev-bioeng-071811-150124
The effect of nanoparticle size, shape, and surface chemistry on biological systems.
Alexandre Albanese (2012)
10.3109/17435390.2011.626534
Risk assessment of engineered nanomaterials: a review of available data and approaches from a regulatory perspective
D. Hristozov (2012)
10.1016/S1054-3589(08)60246-X
Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents.
K. Widder (1979)
Preclinical experiences with magnetic drug targeting: tolerance and efficacy.
A. Lübbe (1996)
10.1016/j.ejrad.2010.11.036
Combination of vascular endothelial growth factor antisense oligonucleotide therapy and radiotherapy increases the curative effects against maxillofacial VX2 tumors in rabbits.
Lin-feng Zheng (2011)
10.1016/J.JMMM.2014.02.021
3-Dimensional quantitative detection of nanoparticle content in biological tissue samples after local cancer treatment
H. Rahn (2014)
10.1016/j.jconrel.2011.01.033
A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo.
A. David (2011)
10.1016/J.JMMM.2006.10.1205
In vitro investigation of the behaviour of magnetic particles by a circulating artery model
C. Seliger (2007)
10.1007/s00216-010-3972-5
The emerging field of nanotoxicology
C. Haynes (2010)
10.1056/NEJMOA022749
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
M. Harisinghani (2003)
10.1039/c2nr31185b
Cell "vision": complementary factor of protein corona in nanotoxicology.
M. Mahmoudi (2012)
10.1016/0277-5379(83)90408-X
Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.
K. Widder (1983)
10.1515/ejnm-2014-0001
Cardiovascular therapy through nanotechnology – how far are we still from bedside?
I. Cicha (2014)
10.1084/JEM.58.5.607
INFECTIOUS PAPILLOMATOSIS OF RABBITS : WITH A NOTE ON THE HISTOPATHOLOGY
R. E. Shope (1933)
10.1073/pnas.1424993112
Noninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients
J. Gaglia (2015)
10.2217/nnm.11.88
Nanomaterial cell interactions: are current in vitro tests reliable?
C. Hirsch (2011)
10.1021/la301104a
Impact of the nanoparticle-protein corona on colloidal stability and protein structure.
J. Gebauer (2012)
10.1039/b917195a
Human serum albumin coated iron oxide nanoparticles for efficient cell labeling.
Jin Y. Xie (2010)
10.1002/jbm.a.34507
Real-time cellular analysis as a novel approach for in vitro cytotoxicity testing of medical device extracts.
Sandra N Garcia (2013)
10.1166/JNN.2006.477
Quantification of magnetic nanoparticles by magnetorelaxometry and comparison to histology after magnetic drug targeting.
F. Wiekhorst (2006)
10.1016/J.JMMM.2014.09.005
Endothelial biocompatibility and accumulation of SPION under flow conditions
Jasmin Matuszak (2015)
10.1016/j.cis.2011.04.003
Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles.
S. Laurent (2011)
10.1248/BPB1978.4.624
Biomedical applications of magnetic fluids II. 1) preparation and magnetic guidance of magnetic albumin microsphere for site specific drug delivery in vivo.
Y. Morimoto (1981)
10.1016/J.JMMM.2005.02.036
In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles
C. Alexiou (2005)
10.1016/j.taap.2008.09.030
Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line.
N. Monteiro-Riviere (2009)
10.1111/j.2042-7158.2010.01024.x
Lipid nanoparticles for the delivery of poorly water‐soluble drugs
H. Bunjes (2010)
10.1088/0031-9155/54/18/N03
Magnetorelaxometric quantification of magnetic nanoparticles in an artery model after ex vivo magnetic drug targeting.
H. Richter (2009)
10.1016/0169-409X(95)00039-A
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
G. Storm (1995)
10.1063/1.1984765
Magnetism in Medicine
M. W. Freeman (1960)
10.1088/0022-3727/42/22/224001
TOPICAL REVIEW: Progress in applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2009)
10.1002/ijc.1217
Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation
U. Bilkenroth (2001)
10.1016/J.JCONREL.2004.07.019
Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model.
I. Brigger (2004)
10.1088/0022-3727/36/13/201
TOPICAL REVIEW: Applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2003)



This paper is referenced by
10.1016/J.JMMM.2017.07.033
Magnetic stem cell targeting to the inner ear
T. N. Le (2017)
10.3389/fchem.2018.00619
Magnetic Drug Delivery: Where the Field Is Going
Paige M. Price (2018)
10.3390/nano9050718
Zero-Field and Field-Induced Interactions between Multicore Magnetic Nanoparticles
A. A. Kuznetsov (2019)
10.1016/j.ejpb.2016.01.017
Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting.
J. Zaloga (2016)
10.2217/nnm.15.156
Quo vadis nanomedicine?
M. Barz (2015)
10.1002/adtp.201800092
Externally Induced Drug Release Systems with Magnetic Nanoparticle Carriers: An Emerging Field in Nanomedicine
Matthew D. Norris (2019)
10.1002/chem.201604903
A Bio-Chemosynthetic Approach to Superparamagnetic Iron Oxide-Ansamitocin Conjugates for Use in Magnetic Drug Targeting.
Liang-liang Wang (2017)
SPECIAL FOCUS y Part 1 y Quo vadis nanomedicine: past, present and future
Matthias Barz (2015)
10.1002/chem.201701491
Synthesis of Magnetic-Nanoparticle/Ansamitocin Conjugates-Inductive Heating Leads to Decreased Cell Proliferation In Vitro and Attenuation Of Tumour Growth In Vivo.
K. Seidel (2017)
10.1016/j.colsurfb.2017.09.057
Studies on the adsorption and desorption of mitoxantrone to lauric acid/albumin coated iron oxide nanoparticles.
J. Zaloga (2018)
10.3390/ijms18071388
Analysis of Hypericin-Mediated Effects and Implications for Targeted Photodynamic Therapy
L. Mühleisen (2017)
10.1016/J.JMMM.2016.09.034
Strategies to optimize the biocompatibility of iron oxide nanoparticles – “SPIONs safe by design”
C. Janko (2017)
10.1016/j.colsurfb.2018.11.002
SPIONs functionalized with small peptides for binding of lipopolysaccharide, a pathophysiologically relevant microbial product.
Weronika Karawacka (2019)
10.1002/CITE.201600077
Innovative toxikologische Untersuchungsmethoden für Eisenoxidnanopartikel in der Nanomedizin
C. Janko (2017)
Semantic Scholar Logo Some data provided by SemanticScholar